Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine (Agriflu) in Children and Adolescents
NCT01209780Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2010
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of agriflu in seasonal influenza, sponsored by Novartis. Started Sep 2010; status: completed.
02
Drugs
agriflu
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT01209780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01209780.